SURUNKALI BUYRAK YETISHMOVCHILIGIDA ZAMONAVIY DAVOLASH YONDASHUVLARI
Annotatsiya
Ushbu maqolada surunkali buyrak yetishmovchiligi (SBY)ning
zamonaviy etiopatogenetik jihatlari, erta diagnostika usullari va davolashning
konservativ hamda zamonaviy substitutsion (gemodializ, peritoneal dializ, buyrak
transplantatsiyasi) yondashuvlari tahlil qilingan. Tadqiqot davomida 2020–2025
yillar oralig'idagi xalqaro va mahalliy adabiyotlar, shuningdek klinik amaliyot
ma'lumotlari umumlashtirildi. Natijalar SBYning erta bosqichlarida nefroprotektiv
terapiya, qandli diabet va arterial gipertenziyani nazorat qilish, hamda
multidisiplinar yondashuvning kasallik progressiyasini sezilarli darajada
sekinlashtirishini ko'rsatadi. Maqola amaliyotchi shifokorlar uchun zamonaviy
davolash algoritmlari bo'yicha amaliy tavsiyalar bilan yakunlanadi.
Maqolani onlayn o'qish
##submission.citations##
- 1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of
- Chronic Kidney Disease. Kidney International Supplements, 2024.
- 2. Levin A., Stevens P.E., Bilous R.W. et al. Kidney Disease: Improving Global
- Outcomes (KDIGO) CKD Work Group. Kidney Int., 2021.
- 3. Webster A.C., Nagler E.V., Morton R.L., Masson P. Chronic Kidney Disease.
- The Lancet, 2022.
- 4. Heerspink H.J.L., Stefansson B.V., Correa-Rotter R. et al. Dapagliflozin in
- Patients with Chronic Kidney Disease. New England Journal of Medicine, 2021.
- 5. Tuttle K.R., Agarwal R., Alpers C.E. et al. Molecular mechanisms and therapeutic
- targets for diabetic kidney disease. Kidney International, 2022.
- 6. Ortiz A., Wanner C., Gansevoort R. Chronic kidney disease as cardiovascular risk
- factor in routine clinical practice. European Journal of Preventive Cardiology,
- 2023.
- 7. Saidov A.A., Rashidova M.T. O'zbekistonda surunkali buyrak kasalliklarining
- epidemiologik xususiyatlari. O'zbekiston tibbiyot jurnali, 2023.
- 8. Каримов Х.Я., Тураев Б.Т. Современные методы диагностики и лечения
- хронической почечной недостаточности. Вестник врача, 2022.
- 9. Hou F.F., Xie D., Wang J. et al. Effect of ACE Inhibitors on Progression of
- Chronic Kidney Disease. Journal of the American Society of Nephrology, 2021.
- 10. Bikbov B., Purcell C.A., Levey A.S. et al. Global, regional, and national burden
- of chronic kidney disease. The Lancet, 2020.
- 11. Vart P., Vaduganathan M., Jongs N. et al. Estimated Lifetime Benefit of SGLT2
- Inhibitors in Patients With CKD. Clinical Journal of the American Society of
- Nephrology, 2022.
- 12. Tonelli M., Wanner C. Lipid management in chronic kidney disease: KDIGO
- clinical practice guideline. Annals of Internal Medicine, 2021.
- 13. Abdullaeva D.R. Peritoneal dializning klinik samaradorligi: zamonaviy
- yondashuvlar. Tibbiyot va sport, 2024.